|
US4427660A
(en)
|
1982-03-03 |
1984-01-24 |
Research Corporation |
Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
|
|
US5166135A
(en)
|
1988-09-12 |
1992-11-24 |
Merck & Company, Inc. |
Method for the control of pneumocystis carinii
|
|
US6030944A
(en)
|
1991-10-01 |
2000-02-29 |
Merck & Co., Inc. |
Cyclohexapeptidyl bisamine compounds
|
|
US5399552A
(en)
|
1991-10-17 |
1995-03-21 |
Merck & Co, Inc |
Antibiotic peptides bearing aminoalkylthioether moieties
|
|
US5378804A
(en)
|
1993-03-16 |
1995-01-03 |
Merck & Co., Inc. |
Aza cyclohexapeptide compounds
|
|
US6268338B1
(en)
|
1993-04-30 |
2001-07-31 |
Merck & Co., Inc. |
Cyclohexapeptidyl amine compounds
|
|
US5948753A
(en)
|
1993-05-04 |
1999-09-07 |
Merck & Co., Inc. |
Cyclohexapeptidyl propanolamine compounds
|
|
CA2161149A1
(en)
|
1993-05-04 |
1994-11-10 |
James M. Balkovec |
Cyclohexapeptidyl aminoalkyl ethers
|
|
US5541160A
(en)
|
1994-04-04 |
1996-07-30 |
Merck & Co., Inc. |
Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
|
|
US5514651A
(en)
|
1994-09-16 |
1996-05-07 |
Merck & Co., Inc. |
Aza cyclohexapeptide compounds
|
|
US5516756A
(en)
|
1994-10-31 |
1996-05-14 |
Merck & Co., Inc. |
Aza cyclohexapeptide compounds
|
|
CA2211138A1
(en)
|
1995-01-26 |
1996-08-01 |
Merck & Co., Inc. |
Novel antifungal cyclohexapeptides
|
|
US5652213A
(en)
|
1995-05-26 |
1997-07-29 |
Eli Lilly And Company |
Cyclic peptide antifungal agents
|
|
PE63998A1
(es)
|
1996-04-19 |
1998-10-30 |
Merck & Co Inc |
Composiciones anti-fungosas
|
|
USRE38984E1
(en)
|
1996-09-12 |
2006-02-14 |
Merck & Co., Inc. |
Antifungal combination therapy
|
|
IL143563A0
(en)
|
1998-12-09 |
2002-04-21 |
Lilly Co Eli |
Purification of echinocandin cyclopeptide compounds
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
ATE294571T1
(de)
|
1999-03-03 |
2005-05-15 |
Lilly Co Eli |
Echinocandin pharmazeutische zusammensetzungen
|
|
AU771727B2
(en)
|
1999-03-03 |
2004-04-01 |
Eli Lilly And Company |
Processes for making pharmaceutical oral ECB formulations and compositions
|
|
US6309622B1
(en)
|
1999-03-26 |
2001-10-30 |
Protech Professional Products, Inc. |
Antimicrobial denture cleansing compositions
|
|
EP1172105A4
(en)
|
1999-04-16 |
2002-09-04 |
Fujisawa Pharmaceutical Co |
ANTIFUNGAL COMPOSITIONS
|
|
HU0104790D0
(en)
|
2001-11-08 |
2002-01-28 |
Human Rt |
Pharmaceutical combinations for topical application
|
|
US6991800B2
(en)
|
2002-06-13 |
2006-01-31 |
Vicuron Pharmaceuticals Inc. |
Antifungal parenteral products
|
|
WO2005014777A2
(en)
|
2002-10-16 |
2005-02-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions for increasing the efficacy of biologically-active ingredients
|
|
US6913759B2
(en)
|
2003-03-11 |
2005-07-05 |
Curatek Pharmaceuticals Holding, Inc. |
Gel composition and method for treatment of vaginal infections
|
|
EP1654036B1
(en)
|
2003-07-22 |
2007-12-26 |
Theravance, Inc. |
Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
|
|
US20060140990A1
(en)
|
2003-09-19 |
2006-06-29 |
Drugtech Corporation |
Composition for topical treatment of mixed vaginal infections
|
|
US8753819B2
(en)
|
2005-07-26 |
2014-06-17 |
Rutgers, The State University Of New Jersey |
Assays for resistance to echinocandin-class drugs
|
|
WO2007113386A1
(en)
|
2006-03-31 |
2007-10-11 |
Karyon-Ctt Ltd |
Peptide conjugates
|
|
GB0702020D0
(en)
|
2007-02-02 |
2007-03-14 |
Novabiotics Ltd |
Peptides and their use
|
|
US20090238867A1
(en)
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
|
US20100009009A1
(en)
|
2008-07-10 |
2010-01-14 |
Micropure, Inc. |
Method and composition for prevention and treatment of oral fungal infections
|
|
GB0817121D0
(en)
|
2008-09-18 |
2008-10-29 |
Univ St Andrews |
Anti-fungal therapy
|
|
WO2010096868A1
(en)
|
2009-02-25 |
2010-09-02 |
Stiefel Research Australia Pty Ltd |
Topical foam composition
|
|
EP2427477B1
(en)
|
2009-05-07 |
2014-02-26 |
DSM Sinochem Pharmaceuticals Netherlands B.V. |
Method for the preparation of cyclopeptides
|
|
NO2470168T3
(enExample)
|
2009-08-26 |
2018-06-30 |
|
|
|
EP2470190A4
(en)
|
2009-08-27 |
2013-07-17 |
Seachaid Pharmaceuticals Inc |
ECHINOCANDINDERIVATE
|
|
EP2525831B1
(en)
|
2010-01-22 |
2019-05-15 |
Ascendis Pharma A/S |
Carrier-linked carbamate prodrug linkers
|
|
JP5809296B2
(ja)
|
2011-03-03 |
2015-11-10 |
シーチェイド ファーマシューティカルズ，インコーポレーテッド |
抗真菌薬及びそれらの使用
|
|
WO2013017691A1
(en)
|
2011-08-04 |
2013-02-07 |
Medizinische Universität Innsbruck |
Cahgt1p inhibitors for use in the treatment of candidiasis
|
|
US8829053B2
(en)
|
2011-12-07 |
2014-09-09 |
Rochal Industries Llp |
Biocidal compositions and methods of using the same
|
|
KR102236462B1
(ko)
|
2012-03-19 |
2021-04-08 |
시다라 세라퓨틱스, 인코포레이티드 |
에키노칸딘 계열의 화합물에 대한 투여 용법
|
|
CN102766198A
(zh)
|
2012-05-04 |
2012-11-07 |
中国人民解放军第二军医大学 |
一种糖肽类抗真菌化合物及其制备方法与应用
|
|
US20150320675A1
(en)
|
2013-01-18 |
2015-11-12 |
University Of Utah Research Foundation |
Modified Release Osmotic Pump for PH-Responsive Drug Delivery
|
|
WO2014124504A1
(en)
|
2013-02-13 |
2014-08-21 |
Katholieke Universiteit Leuven Ku Leuven Research & Development |
Compositions and methods for treating biofilms
|
|
WO2014145109A1
(en)
|
2013-03-15 |
2014-09-18 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State University |
Sugar-linker-drug conjugates
|
|
JP6254257B2
(ja)
*
|
2013-05-01 |
2017-12-27 |
ネオクリ ピーティーワイ リミテッド |
細菌感染を処置するための方法
|
|
US20160213742A1
(en)
|
2013-09-04 |
2016-07-28 |
Cidara Therapeutics, Inc. |
Compositions and methods for the treatment of fungal infections
|
|
WO2017049105A1
(en)
|
2015-09-16 |
2017-03-23 |
Cidara Therapeutics, Inc. |
Formulations for treating fungal infections
|
|
WO2017049102A1
(en)
|
2015-09-16 |
2017-03-23 |
Cidara Therapeutics, Inc. |
Methods for treating fungal infections
|
|
CN108883152A
(zh)
|
2016-01-08 |
2018-11-23 |
奇达拉治疗公司 |
防止和治疗肺孢子虫感染的方法
|
|
ES2955711T3
(es)
|
2016-03-16 |
2023-12-05 |
Cidara Therapeutics Inc |
Regímenes de dosificación para el tratamiento de infecciones fúngicas
|
|
US20190307843A1
(en)
|
2016-11-01 |
2019-10-10 |
Cidara Therapeutics, Inc. |
Single dose methods for preventing and treating fungal infections
|
|
US20210002346A1
(en)
|
2016-11-29 |
2021-01-07 |
Cidara Therapeutics, Inc |
Methods for preventing fungal infections
|
|
EP3577129A1
(en)
|
2017-01-31 |
2019-12-11 |
Cidara Therapeutics, Inc. |
Methods for treating fungal infections
|
|
WO2018187574A1
(en)
|
2017-04-05 |
2018-10-11 |
Cidara Therapeutics, Inc. |
Compositions and methods for the treatment of fungal infections
|
|
WO2018191692A1
(en)
|
2017-04-14 |
2018-10-18 |
Cidara Therapeutics, Inc. |
Methods for treating fungal infections
|
|
CA3069423C
(en)
|
2017-07-12 |
2025-04-15 |
Napp Pharmaceutical Group Limited |
Formulations for the treatment of fungal infections
|
|
US20200164023A1
(en)
|
2017-08-03 |
2020-05-28 |
Cidara Therapeutics, Inc. |
Methods for preventing and treating intra-abdominal candidiasis
|
|
CA3103619A1
(en)
|
2018-06-15 |
2019-12-19 |
Cidara Therapeutics, Inc. |
Synthesis of echinocandin antifungal agent
|